Facility Evaluation Report

On 11/20/25, Licensing Program Analyst (LPA) Yang arrived unannounced conduct a Case Management deficiency visit. LPA introduce self, stated the purpose of the visit, and met with Resident Care Director Brittney Polman.

The purpose of the today's visit is to address an incident where medications were found in the resident’s room after medication signed off by staff that medications were administered. Interviews were conducted, medications were checked, and records were received. R1’s evening medication Atorvastatin was founded in R1’s room the following day after the medication was signed off that it was administered.

A deficiency is being cited, per California Code of Regulations, Title 22, Division 6, see attached Lic 809D.

An exit interview was conducted. A copy of this report and appeal rights were provided to Resident Care Director, whose signature confirmed receipt of report.